Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Background: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. Case Presentation: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome. Conclusion: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526520999201126203510
2021-09-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526520999201126203510
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test